← 홈

혈액암 (AML/ALL)

858개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 858개
CGTBiologicstaleShenzhen Institute for Innovati…Phase 2

Drugs and anti-CD19 CAR transduced T cells (Drugs and anti-CD19 CAR transduced T cells)

Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 12상태 ACTIVE
CGTBiologicstaleVyriad, Inc.Phase 2

Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter (Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter)

Fallopian Tube Clear Cell Adenocarcinoma; Fallopian Tube Endometrioid Adenocarcinoma · Fallopian Tube Clear Cell Adenocarcinoma

#FallopianTubeClearCellAdenocarci#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 0%임상시험 12상태 ACTIVE
ADCBiologicstaleAmgenPhase 2

YL201 (YL201)

Small Cell Lung Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 12상태 RECRUITING
ADCBiologicstaleShanghai JMT-Bio Inc.Phase 3

JSKN003 (JSKN003)

Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 11상태 RECRUITING
AntibodystaleLepu Medical Technology (Beijin…Phase 2

MRG003+Pucotenlimab (MRG003+Pucotenlimab)

Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma · Locally Advanced Oral and Oropharyngeal

#LocallyAdvancedOralandOropharyng#Antibody#Phase2#항체#면역항체+2
임상시험 11상태 RECRUITING
ADCBiologicstaleCuris, Inc.Phase 1

Emavusertib (Emavusertib)

Metastatic Biliary Tract Cancer; Metastatic Biliary Tract Carcinoma · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 10상태 RECRUITING
CGTBiologicstaleNovartisPhase 1

huCART19 (huCART19)

Acute Lymphocytic Leukemia; Diffuse Large Cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 10상태 ACTIVE
CGTBiologicstaleImmunityBio, Inc.Phase 1

super NK cell (super NK cell)

AML, Adult; Minimal Residual Disease · AML, Adult

#AMLAdult#CGT#Phase1#세포유전치료#CAR-T+5
효능 ORR 0%임상시험 10상태 ACTIVE
ADCBiologicstaleSeagen Inc.Phase 2

CHEP (CHEP)

Lymphoma; Adult T-Cell Leukemia/Lymphoma · Lymphoma

#Lymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 2%임상시험 9상태 RECRUITING
CGTBiologicstaleKitePhase 2

Tecartus (Tecartus)

Acute Lymphoblastic Leukemia; Large B-cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 86%임상시험 9상태 RECRUITING
CGTBiologicStephan Grupp MD PhDPhase 1

CART123 (Anti-CD123 LV redirected T cells, Anti-CD123 LV redirected T cells (CART123))

Acute Myeloid Leukemia (AML) · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 8상태 RECRUITING
ADCBiologicstalePfizerPreclinical

Antibody Drug Conjugate Chemotherapeutic (Antibody Drug Conjugate Chemotherapeutic)

CD33 Positive Acute Myelogenous Leukemia · CD33

#CD33#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 51%임상시험 8상태 ACTIVE
ADCBiologicstaleMedImmune LLCPhase 1

BL22 immunotoxin (BL22 immunotoxin)

Leukemia; Lymphoma · Leukemia

#Leukemia#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 0%임상시험 8상태 ACTIVE
AntibodystaleMacroGenicsPhase 2

Flotetuzumab (Flotetuzumab)

Relapsed Acute Myeloid Leukemia · Relapsed Acute Myeloid Leukemia

#RelapsedAcuteMyeloidLeukemia#Antibody#Phase2#항체#면역항체+2
효능 ORR 0%임상시험 8상태 DISCONTINUED
AntibodyRochePhase 3

atezolizumab (Tecentriq, Atezolizumab and Recombinant Human Hyaluronidase)

Lung Non-Small Cell Carcinoma; Stage II Lung Cancer AJCC v8 · Lung Non-Small Cell Carcinoma

#LungNon-SmallCellCarcinoma#Antibody#Phase3#항체#면역항체+3
효능 ORR 10.5%임상시험 7상태 RECRUITING
CGTBiologicstaleMiltenyi Biotec, Inc.Phase 1

Autologous CAR19 T lymphocytes (Autologous CAR19 T lymphocytes)

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia; Non-Hodgkin's Lymphoma Refractory · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 77.3%임상시험 7상태 RECRUITING
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

CD33 CAR-NK cell (CD33 CAR-NK cell)

AML, Adult; Minimal Residual Disease · CD33

#CD33#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 7상태 ACTIVE
AntibodystaleAstraZenecaPhase 3

MEDI4736 (Durvalumab, Durvalumab (MEDI4736))

Non-small Cell Lung Cancer · Non Small Cell Lung Carcinoma NSCLC

#NonSmallCellLungCarcinomaNSCLC#Antibody#Phase3#항체#면역항체+3
효능 ORR 44%임상시험 7상태 RECRUITING
ADCBiologicShanghai Junshi Bioscience Co.,…Phase 2

JS212 (JS212)

Non-squamous Non-small Cell Lung Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 7상태 RECRUITING
CGTBiologicstaleMiltenyi Biomedicine GmbHPhase 2

MB-CART19.1 (MB-CART19.1)

Precursor B-Lymphoblastic Lymphoma/Leukaemia Refractory · Melanoma Stage III

#MelanomaStageIII#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 7상태 ACTIVE

12 / 43 페이지

← 이전다음 →